Skip to content
Clinical Trials – home

Complex regional pain syndrome Diagnostics

Clinical trials for Complex regional pain syndrome

Recruiting trials first

See all 4 trials →
Quick filters

4 clinical trials in this condition

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fremanezumab
  • Sponsor:Region Midtjylland
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:L-Ascorbic Acid
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Region Hovedstaden
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Esketamine Hydrochloride
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See all 4 trials →filters applied: condition = Complex regional pain syndrome

In short

Complex regional pain syndrome is a challenging condition that requires careful evaluation and early diagnosis to achieve the best possible outcomes. Understanding the diagnostic process can help patients and families navigate their journey with confidence and access appropriate treatment more quickly.

Key points

  • CRPS diagnosis relies on clinical evaluation using the Budapest criteria rather than any single definitive test, making experienced healthcare providers essential for accurate identification.
  • The hallmark feature of CRPS is pain that is disproportionately severe compared to the original injury, often accompanied by visible changes in skin color, temperature, and texture.
  • Early diagnosis dramatically improves outcomes—when treatment begins promptly after symptoms appear, improvement and even complete remission are possible.
  • Tests like bone scans, X-rays, and MRI don't confirm CRPS but help exclude other conditions that might cause similar symptoms, making the diagnostic process one of elimination.
  • The condition is often initially misdiagnosed as cellulitis due to similar appearances of redness, warmth, and swelling, but the presence of severe allodynia should prompt consideration of CRPS.
  • Clinical trial participation requires thorough diagnostic documentation and confirmation through standardized criteria to ensure research integrity and patient safety.
  • Younger patients and those without complicating factors like smoking or diabetes tend to have better recovery outcomes, emphasizing the importance of overall health management.
  • About 85% of people with CRPS experience gradual improvement in their symptoms within the first two years, though many continue to have some degree of pain.

Introduction: Who Should Undergo Diagnostics

If you experience persistent and intense pain following an injury, surgery, or even a minor event like a blood draw, it's important to seek medical evaluation. Complex regional pain syndrome, often called CRPS, typically develops within four to six weeks after an incident, though symptoms can sometimes appear anywhere from one day to a year later. The pain you feel is usually much more severe than what you'd expect from the original injury, and this disproportion is one of the key warning signs that something unusual is happening in your body.

You should consider seeking diagnostics if you notice pain that gets worse over time instead of better, especially if it's accompanied by changes in your skin's appearance, temperature, or texture. The affected area—most commonly an arm, leg, hand, or foot—might feel overly sensitive to touch or temperature changes. Even a light brush against your skin or a gentle breeze might cause intense discomfort.

Early diagnosis is crucial because treatment is most effective when started as soon as possible. In fact, when addressed early, improvement and even complete remission are achievable goals. Waiting too long can allow physical changes to set in, making the condition harder to reverse. Since the symptoms can be easily confused with normal post-injury inflammation or other conditions like infection, many people delay seeing a doctor, which unfortunately allows CRPS to progress.

Anyone experiencing burning pain, swelling, or noticeable color changes in a limb after trauma should not dismiss these symptoms as "just part of healing." The longer CRPS goes undiagnosed and untreated, the more difficult it becomes to manage. This is why awareness among both patients and healthcare providers is so important. If your regular doctor doesn't recognize the pattern, seeking a second opinion from specialists familiar with chronic pain conditions can make a significant difference in your outcome.

It's worth noting that CRPS affects people differently. Women are affected more often than men, and the condition most commonly appears in adults around 40 years of age, though children and teenagers can also develop it. People of European ancestry represent the majority of cases. These patterns can help guide awareness, but anyone experiencing the characteristic symptoms should seek evaluation regardless of demographic factors.

Diagnostic Methods

Diagnosing CRPS is primarily a clinical process, meaning doctors rely heavily on physical examination and your medical history rather than specific laboratory tests. There is no single test that can definitively confirm CRPS, which makes the diagnostic journey sometimes frustrating for patients. Instead, healthcare providers use a process of elimination, ruling out other possible causes while looking for characteristic patterns of symptoms.

The most widely accepted diagnostic approach uses what are called the Budapest criteria. These standardized criteria help doctors identify CRPS by examining whether you have specific types of symptoms across different categories. To meet the criteria, you must have continuing pain that is out of proportion to any triggering event. You also need to report at least one symptom in three of four categories, and show at least one sign on examination in two or more categories.

The four symptom categories include sensory changes, such as increased sensitivity to pain or feeling pain from normally non-painful stimuli; changes related to blood vessels and sweating, like temperature or color changes in your skin; swelling or changes in sweating patterns; and motor or tissue changes, such as decreased range of motion, weakness, tremor, or changes in hair or nail growth. During your examination, the doctor will carefully observe and test for these signs, comparing the affected limb to your unaffected one.

Although no specific test confirms CRPS, doctors may order various examinations to exclude other conditions that might explain your symptoms. These are called ancillary tests. A bone scan might be performed to look for bone changes. This procedure involves injecting a small amount of radioactive substance into your vein, which allows a special camera to visualize your bones. In CRPS, bone scans sometimes show increased uptake of the radioactive material in the affected area, indicating changes in bone metabolism.

X-rays can reveal loss of minerals from your bones, particularly in later stages of the disease. This bone thinning, called osteoporosis, can develop in the affected limb due to the condition. However, X-rays typically appear normal in the early stages of CRPS, which is another reason why early diagnosis can be challenging.

Magnetic resonance imaging, or MRI, creates detailed images of tissues using magnetic fields and radio waves. While an MRI cannot diagnose CRPS directly, it can help rule out other conditions that might be causing your symptoms, such as structural problems, tumors, or other tissue abnormalities. The test is painless but requires lying still in a narrow tube for an extended period, which some people find uncomfortable.

Sweat production tests may be used to measure the amount of perspiration on both limbs. Because CRPS affects the autonomic nervous system—the part of your nervous system that controls automatic functions like sweating—uneven results between your affected and unaffected sides may indicate the presence of the condition.

Some doctors may test skin temperature differences between limbs, as the affected area often feels warmer or cooler than the opposite side. Similarly, changes in skin color—ranging from white and pale to red, purple, or blotchy—are observed during physical examination. These visible autonomic changes are important diagnostic clues that help distinguish CRPS from other pain conditions.

It's important to understand that the diagnosis becomes easier to make in the early stages when symptoms are most active and visible. As time passes, some symptoms may fluctuate or change, making the pattern less clear. This is another reason why seeking evaluation promptly when you first notice unusual symptoms is so valuable. The combination of your reported symptoms, physical examination findings, and tests to rule out other conditions allows experienced physicians to make an accurate diagnosis.

Because CRPS can be difficult to diagnose, it's best to seek evaluation from doctors who have experience with pain conditions. These might include pain specialists, rehabilitation medicine doctors, or neurologists who understand the complex nature of nerve-related pain disorders. Physical therapists who work with CRPS patients can also provide valuable observations about function and movement patterns that support the diagnostic process.

Diagnostics for Clinical Trial Qualification

When patients consider participating in clinical trials for CRPS, they typically need to undergo a thorough diagnostic evaluation to confirm they meet the study's enrollment criteria. Clinical trials are research studies designed to test new treatments or gather more information about existing ones. To ensure the results are meaningful, researchers need to be certain that all participants truly have the condition being studied.

Most clinical trials for CRPS use the Budapest criteria as their standard for diagnosis. This means potential participants must demonstrate the required pattern of symptoms and signs across the specified categories. The trial coordinators will carefully review your medical history, including documentation of the injury or event that triggered your symptoms, and the timeline of how your condition developed.

Researchers conducting clinical trials typically require comprehensive documentation of your diagnosis. This might include medical records from the doctors who have treated you, results from any imaging studies you've had, and detailed descriptions of your symptoms and how they've changed over time. Some trials may require that your diagnosis be confirmed by a specialist before you can enroll, ensuring that only patients with verified CRPS participate in the study.

Clinical trials often have specific inclusion and exclusion criteria beyond just the diagnosis itself. For example, a trial might only accept patients whose CRPS affects a specific body part, or those who have had symptoms for a certain length of time. Some studies focus on acute CRPS—when symptoms have been present for less than six months—while others may specifically seek patients with chronic CRPS that has lasted longer. Understanding these criteria helps determine which trials might be appropriate for your situation.

As part of the screening process for a clinical trial, you may undergo additional diagnostic tests beyond those used for standard diagnosis. These baseline assessments help researchers measure your condition before treatment begins, so they can accurately track any changes that occur during the study. Common baseline measures include pain scales, where you rate your pain intensity; functional assessments that evaluate how well you can use the affected limb; and quality of life questionnaires that capture how CRPS impacts your daily activities and emotional well-being.

Some clinical trials may require specific imaging studies as part of the enrollment process. For instance, a trial testing a treatment aimed at reducing bone changes might require a bone scan or bone density measurement to establish your starting point. Trials examining inflammation might use specialized imaging techniques to measure inflammatory markers in your affected limb. These tests serve both to confirm your eligibility and to provide researchers with objective data to evaluate treatment effectiveness.

Blood tests might also be part of the screening for clinical trials, not to diagnose CRPS itself, but to ensure you don't have other health conditions that might interfere with the study treatment or make participation unsafe for you. For example, if a trial is testing a medication, researchers need to know that your liver and kidneys are functioning well enough to process the drug safely.

The diagnostic requirements for clinical trial participation can seem extensive, but they serve important purposes. They protect your safety by ensuring the experimental treatment is appropriate for your condition and health status. They also protect the integrity of the research by ensuring all participants truly have CRPS and share similar characteristics, which makes the results more reliable and easier to interpret. This careful selection process ultimately helps advance our understanding of CRPS and leads to better treatments for everyone affected by this condition.

Prognosis and Survival Rate

Prognosis

The outlook for people with complex regional pain syndrome varies considerably from person to person. Early studies suggested that most patients recover and have minimal pain after one year. However, more recent research indicates that while pain symptoms and disability tend to improve with time, most people still experience some degree of pain after one year. Despite this, around 85 percent of people with CRPS gradually experience a reduction in their pain and some symptoms within the first two years.

Several factors influence how well someone recovers from CRPS. Early and aggressive treatment significantly improves the chances of preventing chronic, disabling pain. When treatment begins soon after symptoms appear, improvement and even complete remission are possible. Younger people, children, and teenagers generally have better recovery outcomes, as do healthy older adults with good circulation and nutrition.

Certain health factors make recovery more difficult. Smoking and diabetes significantly complicate the healing process, so managing diabetes and quitting smoking can substantially increase a person's chance of recovering from CRPS. Previous chemotherapy treatment can also make recovery more challenging. The severity of the original injury plays a role, but the person's underlying health status is equally important in determining outcomes.

In some people, the signs and symptoms of CRPS go away on their own without any specific treatment. However, for others, symptoms may persist for months or even years. A small percentage of people experience continuous pain despite treatment, and in rare cases, further complications may develop, such as muscle wasting in the affected limb. Once certain physical changes occur, such as skin and nail alterations or muscle tightening, the condition often becomes irreversible.

CRPS can occasionally spread from its original location to other parts of the body, including the opposite limb. While the psychological and emotional impact of living with chronic severe pain can be significant, there is no evidence that people with CRPS have more psychiatric problems than others living with chronic pain conditions. However, depression is present in up to 49 percent of patients with CRPS, highlighting the importance of psychological support as part of comprehensive care.

Survival Rate

Complex regional pain syndrome is not a fatal condition, and it does not directly affect life expectancy. People with CRPS have normal survival rates compared to the general population. The condition primarily impacts quality of life rather than longevity. While CRPS can be extremely debilitating and cause severe chronic pain, it does not damage vital organs or lead to life-threatening complications in the way that some other chronic diseases do.

However, the severe and persistent nature of CRPS pain can significantly affect a person's overall well-being and functioning. The condition can greatly impact the function of the affected limb, sleep patterns, daily activities, and mental health. Some patients find that CRPS prevents them from working or carrying out their usual activities, particularly in severe or long-lasting cases. This disability and the chronic nature of the pain can lead to significant psychological challenges that require attention and support.

The intensity of pain in CRPS is notably severe, with patients frequently rating it as 42 out of 50 on the McGill University Pain Scale. This places CRPS among the most painful conditions known to medicine. While this severe pain does not threaten life directly, the psychological impact of living with such intense chronic pain requires comprehensive support, including psychological counseling and pain management strategies to maintain quality of life and overall functioning.

Did you know?

  1. The incidence of CRPS after a simple fracture ranges from 0.05% to 7% depending on the study, with more recent research showing higher rates than older studies—possibly because we've gotten better at recognizing the condition.
  2. CRPS can be triggered by events as minor as a blood draw, and in some cases, patients cannot even remember the original triggering event, making the diagnostic timeline particularly challenging.
  3. Because CRPS symptoms initially look like cellulitis—with redness, warmth, and swelling—it is frequently misdiagnosed at first, leading to delays in proper treatment that can affect long-term outcomes.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.